Vycor Medical (VYCO) Cash from Operations Growth (1y) (2011 - 2026)
Vycor Medical (VYCO) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.01 Bn | 175.72 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 128.76 Bn | 125.88 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 47.96 Bn | 44.29 Bn | 1.29 Bn | -84.38% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | 16.00% |
| 7 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 185.96% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.44 Bn | 22.31 Bn | 2.07 Bn | 122.43% |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 469.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 469.47% |
| Dec 31, 2025 | 202.48% |
| Sep 30, 2025 | -791.76% |
| Jun 30, 2025 | -45.80% |
| Mar 31, 2025 | -1,526.02% |
| Dec 31, 2024 | -795.01% |
| Sep 30, 2024 | 170.44% |
| Jun 30, 2024 | 507.41% |
| Mar 31, 2024 | -92.34% |
| Dec 31, 2023 | 116.51% |
| Sep 30, 2023 | 80.63% |
| Jun 30, 2023 | 150.34% |
| Mar 31, 2023 | 131.25% |
| Dec 31, 2022 | -206.04% |
| Sep 30, 2022 | -23.00% |
| Jun 30, 2022 | -132.54% |
| Mar 31, 2022 | -130.62% |
| Dec 31, 2021 | 630.49% |
| Sep 30, 2021 | 61.89% |
| Jun 30, 2021 | 294.22% |